Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Zoom Video Communications, Inc. (ZM) Price & Performance

Cassava Sciences IncTrade
Zoom Video Communications, Inc.Trade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Zoom Video Communications, Inc. — how do they compare? Cassava Sciences Inc trades at $1.08 (market cap $53.14M), while Zoom Video Communications, Inc. trades at $94.09 (market cap $27.15B). The key difference: Zoom Video Communications, Inc. is far larger — about 510.9× Cassava Sciences Inc's market cap, and Zoom Video Communications, Inc. is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

FLNAZM
Market Cap
$53.14M$27.15B
Sector
HealthTechnology
52-Week High
$4.64$111.88
52-Week Low
$1.09$69.77
Enterprise Value
-$33.43M$19.49B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Zoom Video Communications, Inc.

Zoom Communications (ZM) trades at $93.03, up 2.07% today, with a bullish technical signal from moving averages and support near $91. The company reported Q1 2026 EPS of $1.55, beating expectations, and maintains strong profitability with a 77.4% gross margin. Recent news highlights AI product launches and the acquisition of Common Room, signaling growth initiatives. Cash flow from operations remains robust at $1.95 billion for 2025, though net cash flow was negative due to investing and financing activities.

The stock appears undervalued with a P/E of 13.64 relative to earnings growth, supported by a $118.79 analyst price target. Key risks include competitive pressure from Microsoft and Google, while the Anthropic stake offers upside potential. Institutional sentiment is mixed with 38.8% buy ratings, but insider selling and fluctuating cash flows warrant caution for near-term volatility.

Returns comparison

Trailing returns across standard periods

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About Zoom Video Communications, Inc.

Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.

Read more on ZM